Chemistry Nobel 2026 goes to Kagan and Soai for work on 'mirror-image' molecules

The Royal Swedish Academy of Sciences awarded the 2026 Nobel Prize in Chemistry on Wednesday, October 7, 2026, to Henri B. Kagan of Universite Paris-Sud in France and Kenso Soai of Tokyo University of Science in Japan. The academy cited their discoveries of non-linear effects and autocatalysis in asymmetric organic synthesis. In simple terms, the two chemists showed how reactions can produce far more of one "mirror-image" version of a molecule than the other, helping to answer a century-old question about why living things use only one version of key molecules such as amino acids. The two share the prize of 12 million Swedish kronor, about 1.2 million US dollars.

Many molecules come in two forms that are mirror images of each other, like a left and a right hand. Chemists call this property chirality. The two forms contain the same atoms but can behave differently in living systems. Life itself uses only one form of amino acids, the building blocks of proteins. Why nature picked one hand has puzzled scientists for more than a hundred years. Kagan's and Soai's work showed how a small imbalance between the two forms can grow on its own into an overwhelming majority, offering a chemical route to that one-handedness.

The practical value is large. Making a medicine with only the correct mirror form is often essential for safety and effectiveness, and doing it efficiently saves money and waste. The methods built on this research help chemists control which form a reaction produces, which matters to every company that makes modern drugs.

That is why the prize is relevant to India, where drug manufacturing is a major industry and chemistry research is carried out in universities and national laboratories. Advances in controlling chirality feed directly into how active drug ingredients are made, how pure they are and how much they cost. For Indian students and researchers, the award is also a reminder that basic questions, such as why life is one-handed, can lead to technologies with huge economic impact.

Short-term: The prize brings attention to asymmetric synthesis and chirality research, which may help attract students and funding to the field.

Long-term: Better control over mirror-image molecules supports cleaner, cheaper and safer production of medicines, flavours and new materials, and deepens scientific understanding of how life began.

Who is affected: Pharmaceutical and fine-chemical manufacturers, chemistry researchers and students, regulators who judge drug purity, and patients who depend on safe medicines.

Questions and Answers